kynurenine has been researched along with chronic COVID syndrome in 5 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examines whether activation of the tryptophan catabolite (TRYCAT) pathway is associated with anxiety symptoms due to Long COVID." | 8.31 | Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway. ( Abed, AK; Al-Hakeim, HK; Almulla, AF; Maes, M; Rouf Moustafa, S, 2023) |
| "This study examines whether activation of the tryptophan catabolite (TRYCAT) pathway is associated with anxiety symptoms due to Long COVID." | 4.31 | Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway. ( Abed, AK; Al-Hakeim, HK; Almulla, AF; Maes, M; Rouf Moustafa, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bizjak, DA | 1 |
| Stangl, M | 1 |
| Börner, N | 1 |
| Bösch, F | 1 |
| Durner, J | 1 |
| Drunin, G | 1 |
| Buhl, JL | 1 |
| Abendroth, D | 1 |
| Ruffieux, H | 1 |
| Hanson, AL | 1 |
| Lodge, S | 1 |
| Lawler, NG | 1 |
| Whiley, L | 1 |
| Gray, N | 1 |
| Nolan, TH | 1 |
| Bergamaschi, L | 1 |
| Mescia, F | 1 |
| Turner, L | 1 |
| de Sa, A | 1 |
| Pelly, VS | 1 |
| Kotagiri, P | 1 |
| Kingston, N | 1 |
| Bradley, JR | 1 |
| Holmes, E | 1 |
| Wist, J | 1 |
| Nicholson, JK | 1 |
| Lyons, PA | 1 |
| Smith, KGC | 1 |
| Richardson, S | 1 |
| Bantug, GR | 1 |
| Hess, C | 1 |
| Cysique, LA | 1 |
| Jakabek, D | 1 |
| Bracken, SG | 1 |
| Allen-Davidian, Y | 1 |
| Heng, B | 1 |
| Chow, S | 1 |
| Dehhaghi, M | 1 |
| Staats Pires, A | 1 |
| Darley, DR | 1 |
| Byrne, A | 1 |
| Phetsouphanh, C | 1 |
| Kelleher, A | 1 |
| Dore, GJ | 1 |
| Matthews, GV | 1 |
| Guillemin, GJ | 1 |
| Brew, BJ | 1 |
| Guo, L | 1 |
| Appelman, B | 1 |
| Mooij-Kalverda, K | 1 |
| Houtkooper, RH | 1 |
| van Weeghel, M | 1 |
| Vaz, FM | 1 |
| Dijkhuis, A | 1 |
| Dekker, T | 1 |
| Smids, BS | 1 |
| Duitman, JW | 1 |
| Bugiani, M | 1 |
| Brinkman, P | 1 |
| Sikkens, JJ | 1 |
| Lavell, HAA | 1 |
| Wüst, RCI | 1 |
| van Vugt, M | 1 |
| Lutter, R | 1 |
| Al-Hakeim, HK | 1 |
| Abed, AK | 1 |
| Almulla, AF | 1 |
| Rouf Moustafa, S | 1 |
| Maes, M | 1 |
5 other studies available for kynurenine and chronic COVID syndrome
| Article | Year |
|---|---|
Kynurenine serves as useful biomarker in acute, Long- and Post-COVID-19 diagnostics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; COVID-19 Testi | 2022 |
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection.
Topics: COVID-19; Humans; Kynurenine; Patient-Centered Care; Post-Acute COVID-19 Syndrome; SARS-CoV-2 | 2023 |
The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC.
Topics: Adult; Biomarkers; Cognitive Dysfunction; COVID-19; Female; Humans; Kynurenine; Male; Middle Aged; P | 2023 |
Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection.
Topics: Chromatography, Liquid; COVID-19; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Leukocyt | 2023 |
Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway.
Topics: Anxiety; COVID-19; Humans; Kynurenine; Post-Acute COVID-19 Syndrome; Tryptophan | 2023 |